The Impact of Pre-Chemotherapy Body Composition and Immunonutritional Markers on Chemotherapy Adherence in Stage III Colorectal Cancer Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Soohyeon | - |
dc.contributor.author | Kang, Dong Hyun | - |
dc.contributor.author | Ahn, Tae Sung | - |
dc.contributor.author | Kim, Seung Soo | - |
dc.contributor.author | Yun, Jong Hyuk | - |
dc.contributor.author | Kim, Hyun Jung | - |
dc.contributor.author | Seo, Seoung Hee | - |
dc.contributor.author | Kim, Tae Wan | - |
dc.contributor.author | Kong, Hye Jeong | - |
dc.contributor.author | Baek, Moo Jun | - |
dc.date.accessioned | 2023-05-25T00:40:13Z | - |
dc.date.available | 2023-05-25T00:40:13Z | - |
dc.date.issued | 2023-02 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/22409 | - |
dc.description.abstract | Patients with colorectal cancer (CRC) often fail to complete full-course chemotherapy with a standard dose due to various reasons. This study aimed to determine whether body composition affects chemotherapy adherence in patients with CRC. The medical records of 107 patients with stage III CRC who underwent adjuvant folinic acid, fluorouracil and oxaliplatin (FOLFOX) chemotherapy at a single center between 2014 and 2018 were analyzed retrospectively. Blood test results for selected immunonutritional markers were analyzed and body composition was measured through computed tomography. Univariate and multivariate analyses were performed on low and high relative dose intensity (RDI) groups, based on an RDI of 0.85. In the univariate analysis, a higher skeletal muscle index was correlated with a higher RDI (p = 0.020). Psoas muscle index was also higher in patients with high RDI than in those with low RDI (p = 0.026). Fat indices were independent of RDI. Multivariate analysis was performed for the aforementioned factors and results showed that age (p = 0.028), white blood cell count (p = 0.024), and skeletal muscle index (p = 0.025) affected RDI. In patients with stage III CRC treated with adjuvant FOLFOX chemotherapy, a decrease in RDI was related to age, white blood cell count, and skeletal muscle index. Therefore, if we adjust the drug dosage in consideration of these factors, we can expect an increased treatment efficiency in patients by increasing chemotherapy compliance. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI AG | - |
dc.title | The Impact of Pre-Chemotherapy Body Composition and Immunonutritional Markers on Chemotherapy Adherence in Stage III Colorectal Cancer Patients | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/jcm12041423 | - |
dc.identifier.scopusid | 2-s2.0-85148944681 | - |
dc.identifier.wosid | 000938597100001 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Medicine, v.12, no.4 | - |
dc.citation.title | Journal of Clinical Medicine | - |
dc.citation.volume | 12 | - |
dc.citation.number | 4 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | COLON-CANCER | - |
dc.subject.keywordPlus | VISCERAL ADIPOSITY | - |
dc.subject.keywordPlus | SKELETAL-MUSCLE | - |
dc.subject.keywordPlus | MASS | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | DETERMINANT | - |
dc.subject.keywordPlus | SARCOPENIA | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | TOXICITY | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordAuthor | body composition | - |
dc.subject.keywordAuthor | chemotherapy adherence | - |
dc.subject.keywordAuthor | relative dose intensity | - |
dc.subject.keywordAuthor | colorectal cancer | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.